Autofluorescent Imaging in Patients With Peritoneal Carcinomatosis
نویسندگان
چکیده
منابع مشابه
Autofluorescent imaging in patients with peritoneal carcinomatosis.
BACKGROUND AND OBJECTIVES Autofluorescence imaging (AFI) is mainly used to detect (pre)cancerous colorectal and pulmonal lesions. This is the first report establishing the feasibility of AFI in patients with peritoneal carcinomatosis (PC). METHODS This is a prospective analysis of 10 patients undergoing conventional white-light laparoscopy (WL) and AFI for PC of different gastrointestinal tum...
متن کاملPeritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis
A 67-year-old male presented with fatigue, abdominal pain , and 30-pound weight loss over 3 months. Computerized tomography (CT) abdomen displayed ascites with thickening and enhancement of the peritoneum and mottled nodular appearing as soft tissue consistent with omental caking worrisome for peritoneal carcinomatosis. A paracentesis revealed white blood cell count of 2,500 with 98% lymphocyte...
متن کاملIntra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
BACKGROUND Intra-peritoneal (i.p.) chemotherapy is an encouraging treatment option for ovarian cancer with peritoneum involvement in addition with intravenous (i.v.) chemotherapy. Intra-operative i.p. chemotherapy is an interesting method of administration by enhancing the diffusion of chemotherapy. This study had assessed the feasibility of intra-operative i.p. chemotherapy in patients with pe...
متن کاملPeritoneal carcinomatosis mimicking a peritoneal tuberculosis
Symptoms of a peritoneal progression from ovarian cancer are nonspecific such as abdominal pain, abdominal distention and more. Many imaging studies and serum CA-125 help diagnosis. However, it is difficult to exclude the instances of the diffuse peritoneal diseases that mimic carcinomatosis. The elevated CA-125 level usually correlates with the peritoneal carcimatosis, but it is often found in...
متن کاملImmunotherapy of peritoneal carcinomatosis with catumaxomab.
Peritonectomy and cytoreductive surgery with or without HIPEC (hyperthermic intraperitoneal chemotherapy) has been performed with some impressive results in patients with PC in slow growing GI tumours [6]. Patients with PC secondary to gastric cancer have been shown to have a median survival of up to 12 months with complete cytoreduction [7]. However, complete cytoreduction is often not possibl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Surgical Innovation
سال: 2013
ISSN: 1553-3506,1553-3514
DOI: 10.1177/1553350613495114